Literature DB >> 11256879

The role of calcium in peri- and postmenopausal women: consensus opinion of The North American Menopause Society.

.   

Abstract

OBJECTIVE: The North American Menopause Society (NAMS) established a goal to review the published medical data and develop an evidence-based consensus opinion regarding the role of calcium in peri- and postmenopausal women.
DESIGN: In building this consensus opinion, NAMS followed the general principles established for evidence-based guidelines. As part of that process, NAMS appointed a panel of clinicians and researchers acknowledged to be experts in the field of calcium. Their advice was used to assist the NAMS Board of Trustees in developing this consensus opinion.
RESULTS: Adequate calcium intake (in the presence of adequate vitamin D intake) has been shown to prevent bone loss and reduce fracture risk in peri- and postmenopausal women. Although calcium is not as effective as antiresorptive agents (e.g., estrogen, selective estrogen-receptor modulators, or bisphosphonates), it is an essential component of antiresorptive agent therapy for osteoporosis. Calcium has also been associated with beneficial effects in several nonskeletal disorders, primarily hypertension, colorectal cancer, obesity, and nephrolithiasis, although the extent of those effects and mechanisms involved have not been fully explored. Estimates of adequate intakes of calcium for peri- and postmenopausal women are based on evidence relating to osteoporosis prevention. At least 1,200 mg/day of calcium is required for most women; levels greater than 2,500 mg/day are not recommended. To ensure adequate calcium absorption, a daily intake of 400-600 IU of vitamin D is recommended, either through sun exposure or through diet or supplementation. Since no accurate test to determine calcium deficiency exists, clinicians should focus instead on ensuring that a woman consumes enough calcium to meet the recommended levels.
CONCLUSION: Although the most definitive role for calcium in peri- and postmenopausal women is in bone health, it is clear that adequate calcium intake has implications that encompass a woman's overall health. Based on the available evidence, a strong statement can be made regarding the importance of ensuring adequate calcium intake in all women, particularly those in peri- or postmenopause.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11256879     DOI: 10.1097/00042192-200103000-00003

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  5 in total

1.  Icariin prevents bone loss by inhibiting bone resorption and stabilizing bone biological apatite in a hindlimb suspension rodent model.

Authors:  Jin-Peng He; Xiu Feng; Ju-Fang Wang; Wen-Gui Shi; He Li; Sergei Danilchenko; Aleksei Kalinkevich; Mykhailo Zhovner
Journal:  Acta Pharmacol Sin       Date:  2018-06-11       Impact factor: 6.150

2.  Dietary calcium but not elemental calcium from supplements is associated with body composition and obesity in Chinese women.

Authors:  Lina Huang; Jingyi Xue; Ying He; Jian Wang; Changhao Sun; Rennan Feng; Jianhua Teng; Yonghan He; Ying Li
Journal:  PLoS One       Date:  2011-12-07       Impact factor: 3.240

3.  Effect of acupuncture and its influence on cerebral activity in perimenopausal insomniacs: study protocol for a randomized controlled trial.

Authors:  Xiao Wu; Wei Zhang; Yuanyuan Qin; Xuguang Liu; Zhengyan Wang
Journal:  Trials       Date:  2017-08-14       Impact factor: 2.279

4.  Use acupuncture to relieve perimenopausal syndrome: study protocol of a randomized controlled trial.

Authors:  Ying Li; Hui Zheng; Qianhua Zheng; Ling Zhao; Erqi Qin; Yu Wang; Qian Zeng; Huabin Zheng; Yu Zhao; Wei Sun; Xiaoxia Zhang; Zhishun Liu; Baoyan Liu
Journal:  Trials       Date:  2014-05-30       Impact factor: 2.279

5.  Screening, supplements and the use of hormonal replacement therapy in postmenopausal women in a family medicine department prior to the publication of the Woman's Health Initiative report.

Authors:  Russel Kirkby; Abdulaziz Al Saif
Journal:  Ann Saudi Med       Date:  2004 May-Jun       Impact factor: 1.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.